Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Fruquintinib and Everolimus
The First People's Hospital of Lianyungang
Renal Cell Carcinoma, Clear Cell, Somatic
1 trial -
G-CSF (Granulocyte colony-stimulating factor)
The First People's Hospital of Lianyungang
Granulocyte Colony-Stimulating Factor (G-CSF) Mobilization
1 trial -
GD007 Low-dose drug group
The First People's Hospital of Lianyungang
Moderate-Severe Intrauterine Adhesions
1 trial -
GDMT
The First People's Hospital of Lianyungang
Heart Failure With Preserved Ejection Fraction
1 trial -
Gastrodin Injection
The First People's Hospital of Lianyungang
Sensorineural Hearing Loss
1 trial -
Gemcitabine, cisplatin
The First People's Hospital of Lianyungang
Bladder Cancer
1 trial -
Ginkgo Biloba Extract
The First People's Hospital of Lianyungang
Acute Ischemic Stroke
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Clinical Pregnancy Rate
1 trial -
GnRH-a
The First People's Hospital of Lianyungang
Infertility, Female
1 trial -
GnRH-a-1M
The First People's Hospital of Lianyungang
Adenomyosis of Uterus
1 trial -
GnRHa
The First People's Hospital of Lianyungang
Cesarean Scar Diverticula
1 trial -
Gold omega 3
COLLEGIUM PHARMACEUTICAL, INC
Chronic Kidney Disease
1 trial -
Goserelin
The First People's Hospital of Lianyungang
Allogeneic Haematopoietic Stem Cell Transplantation
1 trial -
Group A (clinical guideline+machine learning)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Guben Kechuan Granules group
Universal Integrated
Chronic Obstructive Pulmonary Disease (COPD)
1 trial -
Guideline-directed medical therapy
The First People's Hospital of Lianyungang
Heart Failure With Reduced Ejection Fraction
1 trial -
HFMS, MRC, ACTIVLIM, PedsQl-4.0
United Therapeutics Europe Ltd
Flaccid Hemiplegia
1 trial -
HG204
The First People's Hospital of Lianyungang
MECP2 Duplication Syndrome
1 trial -
HIV self-testing among female sex workers
United Therapeutics Europe Ltd
Human Immunodeficiency Virus (HIV)
1 trial -
HPV Self-Collection
Hospital Authority, Hong Kong
Cervical Cancers
1 trial -
Health education and conservative management of clinical routines
The First People's Hospital of Lianyungang
Recurrent Acute Pancreatitis
1 trial -
HellenCare
The First People's Hospital of Lianyungang
Alzheimer's Disease Dementia
1 trial -
Heparin Sodium
The First People's Hospital of Lianyungang
Cerebral Aneurysm
1 trial -
High risk experimental group
The First People's Hospital of Lianyungang
Adolescent Idiopathic Scoliosis
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources